Schoedel K A, Sellers E M, Tyndale R F
Department of Pharmacology, University of Toronto, 1 King's College Circle, M5S 1A8, Toronto, Ontario, Canada.
Biochem Pharmacol. 2001 Oct 15;62(8):1025-36. doi: 10.1016/s0006-2952(01)00744-4.
A higher proportion of alcoholics than non-alcoholics smoke (>80 vs 30%). In animals, chronic administration of alcohol induces tolerance to some effects of nicotine. To investigate if chronic ethanol (EtOH) induces alterations in CYP2B1/2 and nicotine C-oxidation activity, male rats (N = 4-6/group) were treated once daily with saline or EtOH (0.3, 1.0, and 3.0 g/kg, p.o./by gavage) for 7 days. A quantitative immunoblotting assay was developed to detect CYP2B1/2 in the brain, where constitutive expression is low, and in the liver. Using this method, it was determined that EtOH did not alter CYP2B1/2 protein expression significantly in six brain regions (olfactory bulbs, olfactory tubercles, frontal cortex, hippocampus, cerebellum, and brainstem). However, a dose-dependent induction of CYP2B1/2 protein expression was detected in the liver. Significant induction of 2-, 3-, and 2.7-fold were observed for the 0.3, 1.0, and 3.0 g/kg doses, respectively. Increases were also observed in CYP2B1 mRNA, which was induced by 14, 38, and 43% at the same doses. Liver microsomal nicotine C-oxidation also was increased (1.3 to 4.5-fold). CYP2B selective inactivators demonstrated that approximately 70% of nicotine C-oxidation was mediated by CYP2B1/2 in both EtOH-induced and uninduced hepatic microsomes. In summary, chronic, behaviorally relevant doses of EtOH induce CYP2B1/2 protein, mRNA, and nicotine C-oxidation activity in rat liver but not in rat brain, and these increases could contribute to cross-tolerance and co-abuse of ethanol and nicotine.
酗酒者中吸烟的比例高于非酗酒者(80%对30%)。在动物实验中,长期给予酒精会诱导对尼古丁某些作用的耐受性。为了研究慢性乙醇(EtOH)是否会诱导CYP2B1/2和尼古丁C氧化活性的改变,将雄性大鼠(每组N = 4 - 6只)每天一次给予生理盐水或EtOH(0.3、1.0和3.0 g/kg,口服/灌胃),持续7天。开发了一种定量免疫印迹法来检测大脑(其组成型表达较低)和肝脏中的CYP2B1/2。使用这种方法确定,EtOH在六个脑区(嗅球、嗅结节、额叶皮质、海马体、小脑和脑干)中并未显著改变CYP2B1/2蛋白表达。然而,在肝脏中检测到了CYP2B1/2蛋白表达的剂量依赖性诱导。分别在0.3、1.0和3.0 g/kg剂量下观察到显著的2倍、3倍和2.7倍诱导。CYP2B1 mRNA也有增加,在相同剂量下分别诱导了14%、38%和43%。肝脏微粒体尼古丁C氧化也增加了(1.3至4.5倍)。CYP2B选择性灭活剂表明,在EtOH诱导和未诱导的肝微粒体中,约70%的尼古丁C氧化是由CYP2B1/2介导的。总之,行为相关剂量的慢性EtOH会诱导大鼠肝脏中CYP2B1/2蛋白、mRNA和尼古丁C氧化活性,但不会诱导大鼠大脑中的这些变化,这些增加可能导致乙醇和尼古丁的交叉耐受性和共同滥用。